Keyphrases
Drug Levels
100%
Inflammatory Bowel Disease
100%
Therapeutic Drug Monitoring
100%
Tumour Necrosis Factor Inhibitor (TNFi)
100%
Anti-drug Antibodies
100%
Treatment Optimization
100%
Treatment Failure
66%
Pharmacokinetics
66%
Clinical Outcomes
33%
Pharmacodynamics
33%
Anti-tumor Necrosis Factor Therapy
33%
Disease Activity
16%
Treatment Outcome
16%
Support Use
16%
Pharmacodynamic Response
16%
Anti-tumor Necrosis Factor (anti-TNF)
16%
Lack of Response
16%
Inflammatory Phenotype
16%
Repeated Assessment
16%
Confirmatory Assay
16%
Treatment Goals
16%
Intestinal Inflammation
16%
Result Interpretation
16%
Economic Outcomes
16%
Trough Level
16%
Individualized Treatment
16%
Drug Costs
16%
Number of Factors
16%
Bench to Bedside
16%
Mucosal Healing
16%
Anti-tumor Necrosis Factor Drugs
16%
Methodological Bias
16%
Aid Decision Making
16%
Quiescent Infection
16%
Temporal Bias
16%
Antibody Pharmacokinetics
16%
Pharmacology, Toxicology and Pharmaceutical Science
Therapeutic Drug Monitoring
100%
Tumor Necrosis Factor Inhibitor
100%
Inflammatory Bowel Disease
100%
Pharmacokinetics
71%
Tumor Necrosis Factor
57%
Pharmacodynamics
42%
Side Effect
14%
Disease Activity
14%
Disease
14%
Trough Level
14%